Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Sovaprevir

    DEVELOPMENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 1001667-23-7, Sovaprevir [usan], Ach-0141625, 2nd9v3mn6o, Ach-1625, Sovaprevir (usan)
    Molecular Formula
    C43H53N5O8S
    Molecular Weight
    800.0  g/mol
    InChI Key
    MHFMTUBUVQZIRE-WINRQGAFSA-N
    FDA UNII
    2ND9V3MN6O
    Sovaprevir has been investigated for the treatment of Hepatitis C, Chronic.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S,4R)-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide
    2.1.2 InChI
    InChI=1S/C43H53N5O8S/c1-6-28-25-43(28,41(52)46-57(53,54)31-16-17-31)45-39(50)36-22-30(26-48(36)40(51)33(42(2,3)4)23-38(49)47-19-11-8-12-20-47)56-37-24-34(27-13-9-7-10-14-27)44-35-21-29(55-5)15-18-32(35)37/h6-7,9-10,13-15,18,21,24,28,30-31,33,36H,1,8,11-12,16-17,19-20,22-23,25-26H2,2-5H3,(H,45,50)(H,46,52)/t28-,30-,33-,36+,43-/m1/s1
    2.1.3 InChI Key
    MHFMTUBUVQZIRE-WINRQGAFSA-N
    2.1.4 Canonical SMILES
    CC(C)(C)C(CC(=O)N1CCCCC1)C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=CC(=NC6=C5C=CC(=C6)OC)C7=CC=CC=C7
    2.1.5 Isomeric SMILES
    CC(C)(C)[C@H](CC(=O)N1CCCCC1)C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=CC(=NC6=C5C=CC(=C6)OC)C7=CC=CC=C7
    2.2 Other Identifiers
    2.2.1 UNII
    2ND9V3MN6O
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 1001667-23-7

    2. Sovaprevir [usan]

    3. Ach-0141625

    4. 2nd9v3mn6o

    5. Ach-1625

    6. Sovaprevir (usan)

    7. 2-pyrrolidinecarboxamide, N-[(1r,2s)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2s)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2s,4r)-

    8. Sovaprevir [usan:inn]

    9. Unii-2nd9v3mn6o

    10. Sovaprevir [inn]

    11. Prodrug Of Ach-1095

    12. Sovaprevir [who-dd]

    13. Schembl1462843

    14. Chembl2105750

    15. Dtxsid00142994

    16. Chebi:177769

    17. Db12069

    18. (2s,4r)-n-[(1r,2s)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2s)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide

    19. D10166

    20. Q16892599

    21. (2s,4r)-1-((2s)-2-tert-butyl-4-oxo-4-(piperidin-1-yl)butanoyl)-n-((1r,2s)-1-((cyclopropanesulfonyl)carbamoyl)-2-ethenylcyclopropyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidine-2-carboxamide

    22. (2s,4r)-1-((s)-2-(tert-butyl)-4-oxo-4-(piperidin-1-yl)butanoyl)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidine-2-carboxamide

    23. (2s,4r)-1-((s)-2-tert-butyl-4-oxo-4-(piperidin-1-yl)butanoyl)-n-((1r,2s)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(7-methoxy-2-phenylquinolin-4-yloxy)pyrrolidine-2-carboxamide

    24. (2s,4r)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-ethenylcyclopropyl)-1-((2s)- 3,3-dimethyl-2-(2-oxo-2-(piperidin-1-yl)ethyl)butanoyl)-4-((7-methoxy-2-phenylquinolin- 4-yl)oxy)pyrrolidine-2-carboxamide

    25. (2s,4r)-n-[(1r,2s)-1-(cyclopropylsulfonylcarbamoyl)-2-vinyl-cyclopropyl]-1-[(2s)-3,3-dimethyl-2-[2-oxo-2-(1-piperidyl)ethyl]butanoyl]-4-[(7-methoxy-2-phenyl-4-quinolyl)oxy]pyrrolidine-2-carboxamide

    26. (2s,4r)-n-[(1r,2s)-1-(cyclopropylsulonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2s)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide

    27. 2-pyrrolidinecarboxamide, N-((1r,2s)-1-(((cyclopropylsulfonyl)amino)carbonyl)-2- Ethenylcyclopropyl)-1-((2s)-3,3-dimethyl-1-oxo-2-(2-oxo-2-(1-piperidinyl)ethyl)butyl)-4-

    2.4 Create Date
    2011-09-26
    3 Chemical and Physical Properties
    Molecular Weight 800.0 g/mol
    Molecular Formula C43H53N5O8S
    XLogP35.2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count14
    Exact Mass799.36148484 g/mol
    Monoisotopic Mass799.36148484 g/mol
    Topological Polar Surface Area173 Ų
    Heavy Atom Count57
    Formal Charge0
    Complexity1610
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.